Copyright Reports & Markets. All rights reserved.

Global Oral Solid Dosage CDMO Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Oral Solid Dosage CDMO by Type
    • 1.3.1 Overview: Global Oral Solid Dosage CDMO Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Oral Solid Dosage CDMO Consumption Value Market Share by Type in 2024
    • 1.3.3 Chemical Drug CDMO
    • 1.3.4 Biological Drug CDMO
  • 1.4 Global Oral Solid Dosage CDMO Market by Application
    • 1.4.1 Overview: Global Oral Solid Dosage CDMO Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Ordinary Oral Solid Preparations
    • 1.4.3 High-Activity and Special Preparations
  • 1.5 Global Oral Solid Dosage CDMO Market Size & Forecast
  • 1.6 Global Oral Solid Dosage CDMO Market Size and Forecast by Region
    • 1.6.1 Global Oral Solid Dosage CDMO Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Oral Solid Dosage CDMO Market Size by Region, (2020-2031)
    • 1.6.3 North America Oral Solid Dosage CDMO Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Oral Solid Dosage CDMO Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Oral Solid Dosage CDMO Market Size and Prospect (2020-2031)
    • 1.6.6 South America Oral Solid Dosage CDMO Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Oral Solid Dosage CDMO Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Adragos Pharma
    • 2.1.1 Adragos Pharma Details
    • 2.1.2 Adragos Pharma Major Business
    • 2.1.3 Adragos Pharma Oral Solid Dosage CDMO Product and Solutions
    • 2.1.4 Adragos Pharma Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Adragos Pharma Recent Developments and Future Plans
  • 2.2 Aenova
    • 2.2.1 Aenova Details
    • 2.2.2 Aenova Major Business
    • 2.2.3 Aenova Oral Solid Dosage CDMO Product and Solutions
    • 2.2.4 Aenova Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Aenova Recent Developments and Future Plans
  • 2.3 Agno Pharma
    • 2.3.1 Agno Pharma Details
    • 2.3.2 Agno Pharma Major Business
    • 2.3.3 Agno Pharma Oral Solid Dosage CDMO Product and Solutions
    • 2.3.4 Agno Pharma Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Agno Pharma Recent Developments and Future Plans
  • 2.4 Alcami
    • 2.4.1 Alcami Details
    • 2.4.2 Alcami Major Business
    • 2.4.3 Alcami Oral Solid Dosage CDMO Product and Solutions
    • 2.4.4 Alcami Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Alcami Recent Developments and Future Plans
  • 2.5 Almac
    • 2.5.1 Almac Details
    • 2.5.2 Almac Major Business
    • 2.5.3 Almac Oral Solid Dosage CDMO Product and Solutions
    • 2.5.4 Almac Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Almac Recent Developments and Future Plans
  • 2.6 Cambrex
    • 2.6.1 Cambrex Details
    • 2.6.2 Cambrex Major Business
    • 2.6.3 Cambrex Oral Solid Dosage CDMO Product and Solutions
    • 2.6.4 Cambrex Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Cambrex Recent Developments and Future Plans
  • 2.7 Rubicon Research
    • 2.7.1 Rubicon Research Details
    • 2.7.2 Rubicon Research Major Business
    • 2.7.3 Rubicon Research Oral Solid Dosage CDMO Product and Solutions
    • 2.7.4 Rubicon Research Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Rubicon Research Recent Developments and Future Plans
  • 2.8 Catalent Pharma Solutions
    • 2.8.1 Catalent Pharma Solutions Details
    • 2.8.2 Catalent Pharma Solutions Major Business
    • 2.8.3 Catalent Pharma Solutions Oral Solid Dosage CDMO Product and Solutions
    • 2.8.4 Catalent Pharma Solutions Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Catalent Pharma Solutions Recent Developments and Future Plans
  • 2.9 Hetero
    • 2.9.1 Hetero Details
    • 2.9.2 Hetero Major Business
    • 2.9.3 Hetero Oral Solid Dosage CDMO Product and Solutions
    • 2.9.4 Hetero Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Hetero Recent Developments and Future Plans
  • 2.10 Ind-Swift Laboratories
    • 2.10.1 Ind-Swift Laboratories Details
    • 2.10.2 Ind-Swift Laboratories Major Business
    • 2.10.3 Ind-Swift Laboratories Oral Solid Dosage CDMO Product and Solutions
    • 2.10.4 Ind-Swift Laboratories Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Ind-Swift Laboratories Recent Developments and Future Plans
  • 2.11 Lonza
    • 2.11.1 Lonza Details
    • 2.11.2 Lonza Major Business
    • 2.11.3 Lonza Oral Solid Dosage CDMO Product and Solutions
    • 2.11.4 Lonza Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Lonza Recent Developments and Future Plans
  • 2.12 PharmaSource
    • 2.12.1 PharmaSource Details
    • 2.12.2 PharmaSource Major Business
    • 2.12.3 PharmaSource Oral Solid Dosage CDMO Product and Solutions
    • 2.12.4 PharmaSource Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 PharmaSource Recent Developments and Future Plans
  • 2.13 Recipharm
    • 2.13.1 Recipharm Details
    • 2.13.2 Recipharm Major Business
    • 2.13.3 Recipharm Oral Solid Dosage CDMO Product and Solutions
    • 2.13.4 Recipharm Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Recipharm Recent Developments and Future Plans
  • 2.14 Rottendorf Pharma
    • 2.14.1 Rottendorf Pharma Details
    • 2.14.2 Rottendorf Pharma Major Business
    • 2.14.3 Rottendorf Pharma Oral Solid Dosage CDMO Product and Solutions
    • 2.14.4 Rottendorf Pharma Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Rottendorf Pharma Recent Developments and Future Plans
  • 2.15 Abbott
    • 2.15.1 Abbott Details
    • 2.15.2 Abbott Major Business
    • 2.15.3 Abbott Oral Solid Dosage CDMO Product and Solutions
    • 2.15.4 Abbott Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Abbott Recent Developments and Future Plans
  • 2.16 Skyepharma
    • 2.16.1 Skyepharma Details
    • 2.16.2 Skyepharma Major Business
    • 2.16.3 Skyepharma Oral Solid Dosage CDMO Product and Solutions
    • 2.16.4 Skyepharma Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Skyepharma Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Oral Solid Dosage CDMO Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Oral Solid Dosage CDMO by Company Revenue
    • 3.2.2 Top 3 Oral Solid Dosage CDMO Players Market Share in 2024
    • 3.2.3 Top 6 Oral Solid Dosage CDMO Players Market Share in 2024
  • 3.3 Oral Solid Dosage CDMO Market: Overall Company Footprint Analysis
    • 3.3.1 Oral Solid Dosage CDMO Market: Region Footprint
    • 3.3.2 Oral Solid Dosage CDMO Market: Company Product Type Footprint
    • 3.3.3 Oral Solid Dosage CDMO Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Oral Solid Dosage CDMO Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Oral Solid Dosage CDMO Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Oral Solid Dosage CDMO Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Oral Solid Dosage CDMO Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Oral Solid Dosage CDMO Consumption Value by Type (2020-2031)
  • 6.2 North America Oral Solid Dosage CDMO Market Size by Application (2020-2031)
  • 6.3 North America Oral Solid Dosage CDMO Market Size by Country
    • 6.3.1 North America Oral Solid Dosage CDMO Consumption Value by Country (2020-2031)
    • 6.3.2 United States Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Oral Solid Dosage CDMO Consumption Value by Type (2020-2031)
  • 7.2 Europe Oral Solid Dosage CDMO Consumption Value by Application (2020-2031)
  • 7.3 Europe Oral Solid Dosage CDMO Market Size by Country
    • 7.3.1 Europe Oral Solid Dosage CDMO Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
    • 7.3.3 France Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Oral Solid Dosage CDMO Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Oral Solid Dosage CDMO Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Oral Solid Dosage CDMO Market Size by Region
    • 8.3.1 Asia-Pacific Oral Solid Dosage CDMO Consumption Value by Region (2020-2031)
    • 8.3.2 China Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
    • 8.3.5 India Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Oral Solid Dosage CDMO Consumption Value by Type (2020-2031)
  • 9.2 South America Oral Solid Dosage CDMO Consumption Value by Application (2020-2031)
  • 9.3 South America Oral Solid Dosage CDMO Market Size by Country
    • 9.3.1 South America Oral Solid Dosage CDMO Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Oral Solid Dosage CDMO Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Oral Solid Dosage CDMO Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Oral Solid Dosage CDMO Market Size by Country
    • 10.3.1 Middle East & Africa Oral Solid Dosage CDMO Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Oral Solid Dosage CDMO Market Drivers
  • 11.2 Oral Solid Dosage CDMO Market Restraints
  • 11.3 Oral Solid Dosage CDMO Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Oral Solid Dosage CDMO Industry Chain
  • 12.2 Oral Solid Dosage CDMO Upstream Analysis
  • 12.3 Oral Solid Dosage CDMO Midstream Analysis
  • 12.4 Oral Solid Dosage CDMO Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our latest research, the global Oral Solid Dosage CDMO market size will reach USD 2679 million in 2031, growing at a CAGR of 6.2% over the analysis period.
    Oral solid dosage CDMO (Contract Development and Manufacturing Organization) is a professional outsourcing model that provides pharmaceutical companies with a full chain of services from drug research and development, process development, pilot scale-up, clinical sample production to commercial production. Its core lies in helping customers shorten the R&D cycle, reduce production costs, and achieve rapid transformation of products from laboratory to market through the integration of technology platforms and production capabilities.

    This report is a detailed and comprehensive analysis for global Oral Solid Dosage CDMO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Oral Solid Dosage CDMO market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Oral Solid Dosage CDMO market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Oral Solid Dosage CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Oral Solid Dosage CDMO market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Oral Solid Dosage CDMO
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Oral Solid Dosage CDMO market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Adragos Pharma, Aenova, Agno Pharma, Alcami, Almac, Cambrex, Rubicon Research, Catalent Pharma Solutions, Hetero, Ind-Swift Laboratories, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Oral Solid Dosage CDMO market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Chemical Drug CDMO
    Biological Drug CDMO
    Market segment by Application
    Ordinary Oral Solid Preparations
    High-Activity and Special Preparations
    Market segment by players, this report covers
    Adragos Pharma
    Aenova
    Agno Pharma
    Alcami
    Almac
    Cambrex
    Rubicon Research
    Catalent Pharma Solutions
    Hetero
    Ind-Swift Laboratories
    Lonza
    PharmaSource
    Recipharm
    Rottendorf Pharma
    Abbott
    Skyepharma
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Oral Solid Dosage CDMO product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Oral Solid Dosage CDMO, with revenue, gross margin, and global market share of Oral Solid Dosage CDMO from 2020 to 2025.
    Chapter 3, the Oral Solid Dosage CDMO competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Oral Solid Dosage CDMO market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Oral Solid Dosage CDMO.
    Chapter 13, to describe Oral Solid Dosage CDMO research findings and conclusion.

    Buy now